We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

OSI Sues Teva, Mylan Over Cancer Drug Patents

Law360 (March 20, 2009, 12:00 AM EDT) -- OSI Pharmaceuticals Inc. has targeted Teva Pharmaceuticals USA Inc. and Mylan Pharmaceuticals Inc. in patent infringement litigation to stop them from taking steps to market a generic version of cancer treatment...
To view the full article, register now.